11
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T1698 | Carvedilol EP IMpurity E | Carvedilol USP E,Carvedilol Impurity E | Others |
Carvedilol EP IMpurity E (Carvedilol USP E) is used as a pharmaceutical intermediate. | |||
T0342 | Carvedilol phosphate hemihydrate | Carvedilol phosphate,BM 14190 (phosphate hemihydrate) | VEGFR , Others , Potassium Channel , LDL , Integrin , Gap Junction Protein , NADPH , Adrenergic Receptor , Autophagy |
Carvedilol phosphate hemihydrate (BM 14190 phosphate hemihydrate) is the phosphate salt form of carvedilol, a racemic mixture and adrenergic blocking agent with antihypertensive activity and devoid of intrinsic sympathom... | |||
T10686 | Carvedilol metabolite 4-Hydroxyphenyl Carvedilol | 4-Hydroxyphenyl Carvedilol,4-Hydroxycarvedilol | Others |
4-Hydroxyphenyl Carvedilol is a metabolite of Carvedilol. Carvedilol is a beta-blocker/alpha-1 blocker. | |||
T35845 | (R,S)-Carvedilol Glucuronide | ||
(R,S)-Carvedilol glucuronide is a racemic mixture of the carvedilol metabolites (R)-carvedilol glucuronide and (S)-carvedilol glucuronide. (R)-Carvedilol glucuronide is formed via glucuronidation of (R)-carvedilol by the... | |||
T19136 | 4-Hydroxyphenyl Carvedilol-d5 | 4-Hydroxycarvedilol D5,4-Hydroxyphenyl Carvedilol D5 | Others |
4-Hydroxyphenyl Carvedilol D5 is the deuterium labeled 4-Hydroxyphenyl Carvedilol. | |||
T12794 | (S)-Carvedilol | (S)-BM 14190 | Others |
(S)-Carvedilol is a non-selective β/α-1 blocker.It exerts protection against the vascular or cardiac toxicity of Doxorubicin (DOX). | |||
T12615 | (R)-Carvedilol | (R)-BM 14190 | Others |
(R)-Carvedilol is a non-selective blocker of β/α-1. (R)-Carvedilol exerts protection against the vascular or cardiac toxicity of Doxorubicin (DOX). | |||
T8863 | VK-II-36 | Others | |
VK-II-36, a carvedilol analog, suppresses sarcoplasmic reticulum (SR) Ca(2+) release but does not block the β-receptor. | |||
T8891 | Homo-VK-II-36 | Homo-V-II-36 | Others |
Homo-VK-II-36 (Homo-V-II-36) is a carvedilol analogue that acts by inhibiting store- overload-induced calcium release through the RyR2 channel. | |||
T28675 | SB 211475 | SB-211475,SB211475 | |
SB 211475, a metabolite of carvedilol, is a novel antihypertensive agent and a potent antioxidant. | |||
T8965 | VK-II-86 | Others | |
VK-II-86 is a non-β-blocking carvedilol analog. It prevents ouabain-Induced cardiotoxicity |